High-risk patients receiving life-saving medications have the greatest risk of harm from delays or interruption of infusion. Problems with infusion could even lead to death for these patients, BD said in its Aug. 4, 2020 Urgent Medical Device Recall letter for its BD Alaris PC Unit Model 80...
TOPIC: Alaris System Infusion Pumps by Becton Dickinson (BD) CareFusion 303: Class I Recall – Due to Software and System Errors AUDIENCE: Health Professional, Nursing, Risk Manager ISSUE: BD/CareFusion 303 is recalling the Alaris Infusion Pump System and Modules due to multiple syste...
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced that the updated BD Alaris™ Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial o